Leukaemia

This study is looking at whether diet and exercise can improve the health of people with chronic lymphocytic leukaemia (CLL).

This trial is looking at zilovertamab vedotin by itself or in combination with nemtabrutinib for people with B cell lymphomas and B cell leukaemia.

This trial looked at an immunotherapy drug called magrolimab alone or with azacitidine for acute myeloid leukaemia (AML) and myelodysplastic syndrome (MDS).

This trial is comparing ibrutinib with, and without, treatment breaks. It is for people that have had ibrutinib for chronic lymphocytic leukaemia before.

This study is assessing the value of prehabilitation for people with acute myeloid leukaemia and myelodysplastic syndrome.

This trial is looking at the best way to treat acute lymphoblastic leukaemia (ALL) that is Philadelphia chromosome positive.

This trial is looking at MK-1026 for blood cancer that has come back or following treatment that has stopped working.

This trial is comparing standard treatment with 2 newer combinations of treatment to prevent GvHD.